JEANNIE ENGLISH: Open Payments
NPI 1275987554 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 11 payments from 9 companies in 2025. Trend: 2023 $682 · 2024 $610 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $40 |
| Amgen Inc. | 2 | $31 |
| Novo Nordisk Inc | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Abbott Laboratories | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Medtronic, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
Products named: OTEZLA, Ozempic, SHINGRIX, AREXVY, UBRELVY, ETERNA, Symbravo, GEMTESA.
Industry payments across GA — which companies pay providers there.
